PARSIPPANY, NJ, Apr 28, 2010 (MARKETWIRE via COMTEX) --The Medicines Company (NASDAQ: MDCO) will present at the Deutsche Bank 35th Annual Health Care Conference on Wednesday , May 5th, in Boston, beginning at 12:55pm Eastern Time. Glenn Sblendorio, Executive Vice President and Chief Financial Officer, will provide a company overview and outlook in the presentation.

The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com under "Events."

About The Medicines Company The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company's website is www.themedicinescompany.com.

Contact:
Michael Mitchell
The Medicines Company
973-290-6000
investor.relations@themedco.com

SOURCE: The Medicines Company

mailto:investor.relations@themedco.com